Neuroradiology · 2026
Differential atrophy along the longitudinal axis of the hippocampus in Alzheimer's disease and suspected non-Alzheimer's disease pathophysiology (SNAP).
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Meira Torcato, Morais-Ribeiro Rafaela, Jesus Tiago, Dias Marcelo, Coelho Ana, Oliveira Tiago Gil
Аннотация
PURPOSE: Cerebrospinal fluid (CSF) biomarkers are increasingly used to support Alzheimer's disease (AD) diagnosis: Alzheimer's Disease continuum (ADc) is defined by abnormal amyloid-beta (Aβ), while Suspected Non-AD Pathophysiology (SNAP) refers to normal Aβ with elevated tau. Given the differential properties along the hippocampal longitudinal axis, this study aimed to evaluate anterior-posterior subregional hippocampal volume differences among ADc, SNAP, and biomarker-negative participants, and their associations with CSF biomarkers and clinical presentation.
METHODS: Data from 1242 participants in the Alzheimer's Disease Neuroimaging Initiative were analyzed. Biomarker-negative participants (n = 234) had normal CSF Aβ42 (≥ 192 pg/ml), total tau (< 93 pg/ml), and phosphorylated tau at threonine 181 (< 23 pg/ml). ADc individuals (n = 784) had abnormal Aβ42, and SNAP (n = 224) showed normal Aβ42 with elevated tau. T1-weighted MRI scans were used to segment the hippocampus into anterior, intermediate, and posterior subregions. Controlling for age, sex, and multiple comparisons, groups were compared using one-way ANOVA, and Pearson correlation coefficients were calculated to assess the relationships between volumetric variables and age, CSF biomarkers, or neuropsychological scores.
RESULTS: ADc individuals showed significantly lower total and subregional hippocampal volumes compared with SNAP and biomarker-negative participants (P < 0.001). Normalized volumes to total ipsilateral hippocampal volume revealed greater posterior atrophy (P < 0.001) and relatively higher anterior volume (P < 0.01) in ADc. SNAP and biomarker-negative participants showed stronger correlations between hippocampal volumes and age. Several subregional hippocampal volumes correlated with CSF biomarkers, cognitive performance, neuropsychiatric symptoms, and functional impairment.
CONCLUSION: This study reveals distinct patterns of hippocampal atrophy in ADc and SNAP, enhancing our understanding of their differential pathophysiology and associated clinical features.
METHODS: Data from 1242 participants in the Alzheimer's Disease Neuroimaging Initiative were analyzed. Biomarker-negative participants (n = 234) had normal CSF Aβ42 (≥ 192 pg/ml), total tau (< 93 pg/ml), and phosphorylated tau at threonine 181 (< 23 pg/ml). ADc individuals (n = 784) had abnormal Aβ42, and SNAP (n = 224) showed normal Aβ42 with elevated tau. T1-weighted MRI scans were used to segment the hippocampus into anterior, intermediate, and posterior subregions. Controlling for age, sex, and multiple comparisons, groups were compared using one-way ANOVA, and Pearson correlation coefficients were calculated to assess the relationships between volumetric variables and age, CSF biomarkers, or neuropsychological scores.
RESULTS: ADc individuals showed significantly lower total and subregional hippocampal volumes compared with SNAP and biomarker-negative participants (P < 0.001). Normalized volumes to total ipsilateral hippocampal volume revealed greater posterior atrophy (P < 0.001) and relatively higher anterior volume (P < 0.01) in ADc. SNAP and biomarker-negative participants showed stronger correlations between hippocampal volumes and age. Several subregional hippocampal volumes correlated with CSF biomarkers, cognitive performance, neuropsychiatric symptoms, and functional impairment.
CONCLUSION: This study reveals distinct patterns of hippocampal atrophy in ADc and SNAP, enhancing our understanding of their differential pathophysiology and associated clinical features.